Behavioral and psychiatric disorders in children and adolescents with Down syndrome

Mental Health Aspects of Developmental Disabilities

Volumn 7, Issue 2, 2004, Pages 69-76

  Pary, Robert J ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bipolar disorder; Developmental disability; Down syndrome; Intellectual disability; Mental retardation; Mood disorder; Obsessive compulsive disorder; Psychiatric disorder; Psychosis; Self injurious behavior

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBAMAZEPINE; CITALOPRAM; CLONIDINE; CLOZAPINE; NADOLOL; OLANZAPINE; PAROXETINE; PSYCHOTROPIC AGENT; QUETIAPINE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; VALPROATE SEMISODIUM; ZIPRASIDONE;

AGGRESSION; AGRANULOCYTOSIS; AKATHISIA; ANXIETY DISORDER; AUTISM; AUTOMUTILATION; BEHAVIOR DISORDER; BIPOLAR DISORDER; CARDIOVASCULAR DISEASE; COMPULSION; CONSTIPATION; DEPRESSION; DIABETES MELLITUS; DIPLOPIA; DIZZINESS; DOWN SYNDROME; EXTRAPYRAMIDAL SYMPTOM; HEADACHE; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERPROLACTINEMIA; INSOMNIA; LEUKOPENIA; MAJOR DEPRESSION; MENTAL DISEASE; MYOCARDITIS; NAUSEA; NEUROLEPTIC MALIGNANT SYNDROME; NIGHTMARE; OBSESSIVE COMPULSIVE DISORDER; ORTHOSTATIC HYPOTENSION; OSTEOPOROSIS; PEER REVIEW; PSYCHOSIS; RASH; REVIEW; SEIZURE; SOMNOLENCE;

EID: 2942568481     PISSN: 10573291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (55)

1. Abramowicz M (ed). Drugs for Psychiatric Disorders. Treatment Guidelines from The Medical Letter. 2003;1:69-76.
2. Aman MG, Singh NN, Stewart AW, et al. The aberrant behavior checklist: A behavior rating scale for the assessment of treatment effects. Am J Ment Defic 1985;89:485-491.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Test Revision. Washington, DC: American Psychiatric Association, 2000.
4. Angelopoulou N, Souftas V, Sakadamis A. Bone mineral density in adults with Down's syndrome. Eur Radiol 1999;9:648-651.
5. Armenteros JL, Lewis JE. Citalopram treatment for impulsive aggression in children and adolescents: An open pilot study. J Am Acad Child Adolesc Psychiatry 2002;41:522-529.
6. Bosch JJ, Ringdahl J. Functional analysis of problem behavior in children with mental retardation. MCN Am J Matern Child Nurs 2001;26:307-311.
7. Cantwell DP, Swanson J, Connor DF. Case study: Adverse response to clonidine. J Am Acad Child Adolesc Psychiatry 1997;36:539-544.
8. Charlot L, Fox S, Friedlander R. Obsessional slowness in Down's syndrome. J Intellect Disabil Res 2002;46:517-524.
9. Clark D, Wilson GN. Behavioral assessment of children with Down syndrome using the Reiss psychopathology scale. Am J Med Genet 2003;118A:210-216.
10. Cohen WI. Health care guidelines for individuals with Down syndrome: 1999 revision. Down Syndrome Quar 1999;4:1-15.
11. Collacott RA, Cooper SA, McGrother C. Differential rates of psychiatric disorders in adults with Down's syndrome compared with other mentally handicapped adults. Br J Psychiatry 1992:161:671-674.
12. Connor DF, Barkley RA, Davis HT. A pilot study of methylphenidate, clonidine, or the combination in ADHD comorbid with aggressive oppositional defiant or conduct disorder. Clin Pediatr (Phila) 2000;39:15-25.
13. Connor DF, Glatt SJ, Lopez ID, et al. Psychopharmacology and aggression. I: A meta-analysis of stimulant effects on overt/covert aggression-related behaviors in ADHD. J Am Acad Child Adolesc Psychiatry 2002;41:253-261.
14. Connor DF, Ozbayrak KR, Benjamin S, et al. A pilot study of nadolol for overt aggression in developmentally delayed individuals. J Am Acad Child Adoles Psychiatry 1997;36:826-834.
15. Cooper SA, Collacott RA. Clinical features and diagnostic criteria of depression in Down's syndrome. Br J Psychiatry 1994;165:399-403.
16. Craddock N, Owen M. Is there an inverse relationship between Down's syndrome and bipolar affective disorder? Literature review and genetic implications. J Intellect Disabil Res 1994;38:613-620.
17. Cueva JE, Overall JE, Small AM, et al. Carbamazepine in aggressive children with conduct disorder: A double-blind and placebo-controlled study. J Am Acad Child Adolesc Psychiatry 1996;35:480-490.
18. Cunniff C, Frias JL, Kaye C, et al. American Academy of Pediatrics Committee on Genetics. Health supervision for children with Down syndrome. Pediatrics 2001;107:442-449.
19. Cuskelly M, Dadds M. Behavioural problems in children with Down's syndrome and their siblings. J Child Psychol Psychiatry 1992;33:749-761.
20. Cuskelly M, Gunn P. Maternal reports of behavior of siblings of children with Down syndrome. Am J Ment Retard 1993;97:521-529.
21. Donovan SJ, Stewart JW, Nunes EV, et al. Divalproex treatment for youth with explosive temper and mood lability: A double-blind, placebo-controlled crossover design. Am J Psychiatry 2000;157:818-820.
22. Dykens EM, Shah B, Sagun J, et al. Maladaptive behavior in children and adolescents with Down's syndrome. J Intellect Disabil Res 2002;46:484-492.
23. Dykens E, Shah B. Psychiatric disorders in Prader-Willi syndrome: Epidemiology and management. CNS Drugs 2003;17:167-78.
24. Fiddler DJ, Hodapp RM, Dykens EM. Behavioral phenotypes and special education: Parent report of educational issues for children with Down syndrome, Prader-Willi syndrome, and Williams syndrome. J Spec Edu 2002;36:80-88.
25. Gardner RM, Bird FL, Maguire H, et al. Intensive positive behavior supports for adolescents with acquired brain injury: Long-term outcomes in community settings. J Head Trauma Rehabil 2003;18:52-74.
26. Gath A, Gumley D. Behaviour problems in retarded children with special reference to Down's syndrome. Br J Psychiatry 1986;149:156-161.
27. Hill J. Biological, psychological and social processes in the conduct disorders. J Child Psychol Psychiatry 2002;43:133-164.
28. Kazdin AE. Treatments for aggressive and antisocial children. Child Adolesc Psychiatr Clin N Am 2000;9:841-858.
29. Kent L, Evans J, Paul M, et al. Comorbidity of autistic spectrum disorders in children with Down syndrome. Dev Med Child Neurol 1999;41:153-158
30. Kinnas SJ, Brady HR. Oedipism and Down's syndrome: Case report and review of the literature. Ann Ophthalmol 1985;17:431-433.
31. Khan S, Osinowo T, Pary RJ. Down syndrome and major depressive disorder: A review. Ment Health Aspects Dev Disabil 2002;5:46-52.
32. Lund J. Psychiatric aspects of Down's syndrome. Acta Psychiatr Scand 1988;78:369-374.
33. McCracken JT, McGough J, Shah B, et al. Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002;347:314-321.
34. Myers BA, Pueschel SM. Psychiatric disorders in a population with Down's syndrome. J Nerv Ment Dis 1991:179:609-613.
35. Myers BA, Pueschel SM. Major depression in a small group of adults with Down syndrome. Res Dev Disabil 1995;16:285-299.
36. Pakyurek M, Gutkovich Z, Weintraub S. Reduced aggression in two inpatient children with the treatment of their sleep disorder. J Am Acad Child Adolesc Psychiatry 2002;41:1025.
37. Pappadopulos E, MacIntyre JC II, Crismon ML, et al. Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. J Am Acad Child Adolesc Psychiatry 2003;42:145-161.
38. Pary RJ. Down syndrome update: Obsessional slowness. Habil Ment Healthcare Newslett 1994;13:49-50.
39. Pary RJ, Friedlander R, Capone GT. Bipolar disorder and Down syndrome: Six cases. Ment Health Aspects Dev Disabil 1999;2:59-63.
40. Pary RJ, Loschen EL, Tomkowiak SB. Mood disorders and Down syndrome. Semin Clin Neuropsychiatry 1996;1:148-153.
41. Pary RJ, Strauss D, White JF. A population survey of bipolar disorder in persons with and without Down syndrome. Down Syndrome Quar 1996;1:1-4.
42. Pary RJ, Strauss D, White JF. A population survey of suicide attempts in persons with and without Down syndrome. Down Syndrome Quar 1997;2:12-13.
43. Pelham WE, Gnagy EM, Greiner AR, et al. Behavioral versus behavioral and pharmacological treatment in ADHD children attending a summer treatment program. J Abnorm Child Psychology 2000;28:507-525.
44. Pueschel SM, Bernier JC, Pezzullo JC. Behavioural observations in children with Down's syndrome. J Ment Defic Res 1991;35:502-511.
45. Pynnonen PA, Isometsa ET, Verkaslo MA, et al. Untreated celiac disease and development of mental disorders in children and adolescents. Psychosomatics 2002;43:331-334.
46. Reiss S. The Reiss Screen for Maladaptive Behavior Test Manual. Worthington, OH: International Diagnostic Systems, Inc., 1988.
47. Roizen NJ. Medical care and monitoring for the adolescent with Down syndrome. Adolesc Med 2002;13:345-358.
48. Roizen NJ, Patterson D. Down's syndrome. Lancet 2003;361:1281-1289.
49. Schur SB, Sikich L, Findling RL, et al. Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part 1. A Review. J Am Acad Child Adolesc Psychiatry 2003;42:132-144.
50. Snyder R, Turgay A, Aman M, et al. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. J Am Acad Child Adolesc Psychiatry 2002;41:1026-1036.
51. Sovner R, Hurley AD. "Psychotoform" psychopathology. Habil Ment Healthcare Newslett 1993;12:112-113.
52. Valiquette G. Risperidone in children with autism and serious behavioral problems. N Engl J Med 2002;347:1890-1891.
53. Waechter F. Paroxetine must not be given to patients under 18. BMJ 2003;326:1282.
54. Walz NC, Benson BA. Behavioral phenotypes in children with Down syndrome, Prader-Willi syndrome, or Angelman syndrome. J Dev Disabil 2002;14:307-321.
55. Whitaker-Azmitia PM. Serotonin and brain development: Role in human developmental diseases. Brain Res Bull 2001;56:479-485.